The Lancet Global Health
-
1
[Comment] Global health deserves better criticism
-
2
[Correspondence] Accountability for pandemic financing decisions
-
3
[Comment] Expression of concern: Global feasibility of cervical cancer elimination: a multidimensional scenario-based modelling analysis across 175 countries
-
4
[Articles] 2022 WHO estimates for overall and human papillomavirus test-based cervical cancer screening coverage worldwide: a review and synthetic analysis
-
5
[Articles] Artificial intelligence-supported diabetic retinopathy screening in Tanzania: a randomised controlled trial
-
6
[Correspondence] Refining global models for large-scale food fortification
-
7
[Correspondence] Refining global models for large-scale food fortification
-
8
[Articles] Informing an mpox stockpile investment case: epidemiological modelling and cost–benefit analysis
-
9
[Correspondence] Interpreting the lifetime risk of maternal near miss
-
10
[Comment] Expression of concern—Effect of Brazil’s national human papillomavirus vaccination programme on the incidence of cervical cancer and cervical intraepithelial neoplasia grade 3 in women aged 20–24 years: a population-based study
The Lancet Healthy Longevity
-
1
[Comment] Malnutrition in humanitarian emergencies has no age limit
-
2
[Comment] Palliative care as a fundamental right for older adults in humanitarian crises: closing a persistent inequity gap
-
3
[Series] Addressing the health rights and needs of older adults in humanitarian contexts: the importance of person-centred approaches
-
4
[Comment] Systematically overlooked: older adults in humanitarian emergencies
-
5
[Comment] The invisible gap: sexual and reproductive health and rights for older people in humanitarian emergencies
-
6
[Series] Overlooked and underserved: older adults in humanitarian contexts
-
7
[Series] PARTICIPATE: a rights-based framework to include older people’s health-care needs in humanitarian crises
-
8
[Personal View] Ageing in place: how to evaluate current practices following long-term care reforms
-
9
[Articles] Multimorbidity among older people in three African countries: a population-based cross-sectional study in The Gambia, South Africa, and Zimbabwe
-
10
[Comment] The delirium we do not see
The Lancet HIV
-
1
[Feature] South Africa's paediatric HIV tracking gap
-
2
[Articles] Pharmacokinetics and safety of dolutegravir in term neonates exposed to HIV-1 (IMPAACT 2023): a phase 1, open-label, multicentre study
-
3
[Editorial] Fiji's national HIV emergency
-
4
[Culture] Charting the USA's spiralling HIV response
-
5
[Culture] Using circus skills to tell stories about HIV/AIDS
-
6
[Articles] Epidemiological trends of HIV among individuals aged 15–54 years in South Africa from 2004 to 2025: a population-based, longitudinal cohort study
-
7
[Articles] Long-term immunogenicity and efficacy of the quadrivalent human papillomavirus vaccine in women with HIV: a longitudinal cohort study
-
8
[Comment] Reimagining HIV service integration
-
9
[Articles] Virological failure and treatment interruption among people with unsuppressed viral load on antiretroviral therapy: a cross-sectional analysis of Population-based HIV Impact Assessment surveys in seven sub-Saharan African countries
-
10
[Feature] Early lessons from lenacapavir PrEP roll-out in Zimbabwe
The Lancet Infectious Diseases
-
1
[Corrections] Correction to Lancet Infect Dis 2026; 26: 1095
-
2
[Corrections] Correction to Lancet Infect Dis 2026; published online Oct 12. https://doi.org/10.1016/S1473-3099(26)00469-X
-
3
[Comment] Dilemmas in the management of fluoroquinolone-resistant tuberculosis
-
4
[Review] Effectiveness of respiratory syncytial virus immunisation in practice
-
5
[Corrections] Correction to Lancet Infect Dis 2026; published online Oct 14. https://doi.org/10.1016/S1473-3099(26)00572-4
-
6
[Corrections] Correction to Lancet Infect Dis 2026; published online Oct 15. https://doi.org/10.1016/S1473-3099(26)00574-8
-
7
[Articles] Safety and immunogenicity of an adenoviral-vectored vaccine against Crimean–Congo haemorrhagic fever in the UK (CCHF01): an open-label, first-in-human, non-randomised, phase 1 clinical trial
-
8
[Comment] The inequality of adverse pregnancy outcomes related to Oropouche virus infections
-
9
[Articles] Oropouche virus infection in pregnant women in Rio de Janeiro, Brazil: a prospective cohort study
-
10
[Media Watch] Who fills the silence in a crisis
The Lancet Neurology
-
1
[Review] The role of lifestyle interventions in symptom management and disease modification in Parkinson's disease
-
2
[Comment] Advances in understanding sudden unexpected death in people with drug-resistant epilepsy
-
3
[Articles] Seizure-related biomarkers of sudden unexpected death in epilepsy (SUDEP) in drug-resistant focal epilepsy (REPO2MSE): a prospective, multicentre case–control study
The Lancet Microbe
-
1
[Articles] Novel dengue serotype 4 live virus human challenge: a phase 1 dose optimisation and homologous rechallenge study
-
2
[Articles] Clinical and immunological correlates of CXCR4 coreceptor use in people with HIV-1 receiving antiretroviral therapy in the Netherlands: a multicentre cohort study
-
3
[News] Nigeria responds to Ebola Bundibugyo virus case
-
4
[Correspondence] Diversity analysis of indoor and outdoor fungal bioaerosols: methodological considerations
-
5
[Comment] Expanding Epstein–Barr virus-associated disease burden prioritises vaccine development
-
6
[Comment] US CDC’s 5-day recommendation of the artemether–lumefantrine regimen: lessons from Africa and travellers
-
7
[Articles] Mycobacterium tuberculosis complex strain discordance among people with tuberculosis and a history of household contact: a systematic review and meta-analysis
-
8
[Comment] Antimicrobial selection is only part of the story: from resistance to persistence
-
9
[Articles] Biomarker tests for invasive Candida infection in critically ill patients in the UK (A-Stop): a multicentre diagnostic test accuracy study
-
10
[Articles] Phylogeographical structure and genetic introgression in Salmonella enterica serotype Napoli: a genomic epidemiology study
The Lancet Oncology
-
1
[Articles] Pazopanib alternating with bevacizumab in patients with metastatic clear-cell renal cell carcinoma naive to treatment: a multicentre, single-arm, phase 1/2 trial
-
2
[Articles] Talazoparib plus enzalutamide versus placebo plus enzalutamide in metastatic androgen pathway modulator-resistant (castration-resistant) prostate cancer (TALAPRO-2): a biomarker analysis of circulating tumour DNA and cells for prognosis and mol
-
3
[News] 2026 ESMO Congress
-
4
[News] WHO releases framework for expanding access to early breast cancer care
-
5
[News] Brazil improves access to cancer screening and care
-
6
[News] India caps price of 137 cancer drugs
-
7
[Articles] Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial
-
8
[Articles] Perioperative chemotherapy and stereotactic body radiotherapy versus perioperative chemotherapy alone in patients with high-risk, localised pancreatic cancer (MASTERPLAN): an open-label, phase 2, multicentre, randomised trial of the Australasia
-
9
[News] US EPA research and oversight on carcinogens are in disarray, critics contend
-
10
[News] Proposed Mexican reform would set 60-day limit for cancer treatment
The Lancet Planetary Health
-
1
[Corrections] Correction to Lancet Planet Health 2026; 10: 101459
-
2
[Personal View] Prioritising environmental determinants in health technology assessment: a framework for integrating environmental considerations into health-care decision making
-
3
[Articles] Accounting for global carbon dioxide production from human metabolism between 1985 and 2015: a modelling study
-
4
[Correspondence] “Spinning in circles”: a call for interdisciplinarity and situated data-driven research on urban vulnerability
-
5
[Correspondence] The Capitalocene: an emerging concept in public health in the midst of the current socioecological crisis
-
6
[Editorial] Climate overshoot
-
7
[Comment] Doing less for planetary health
-
8
[Review] Payments for ecosystem services and their effects on health and wellbeing: a systematic review
-
9
[Articles] The perceived impact of extreme weather events on care for people with HIV or tuberculosis and HIV in Zimbabwe: a survey-based multicentre cross-sectional observational study and formative evaluation
-
10
[Feature] The evidence gap behind the data centre boom
The Lancet Psychiatry
-
1
[Insight] In crisis: the mental health system promised me choice, then demanded compliance
-
2
[Comment] Transforming suicide helpline services into resilient global health infrastructure
-
3
[Correspondence] Open Dialogue: challenges in interpreting the ODDESSI trial results
-
4
[Correspondence] Open Dialogue: challenges in interpreting the ODDESSI trial results
-
5
[Correspondence] Open Dialogue: challenges in interpreting the ODDESSI trial results
-
6
[Comment] Towards a convergent biomarker and treatment for obsessive-compulsive disorder
-
7
[Corrections] Correction to Lancet Psychiatry 2026; 13: 852–60
-
8
[Personal View] From discovery to proof: a Translation Evidence Map for precision psychiatry
-
9
[Articles] Sex differences in the efficacy, acceptability, and tolerability of antipsychotics in people with acute schizophrenia: individual participant data pairwise, dose–response, and network meta-analyses
-
10
[Comment] Challenges and implications of enabling community-led mental health initiatives